Targanta Therapeutics, Inc.

Targanta Therapeutics, Inc., headquartered in California, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Novartis AG, from which it inherits climate commitments and initiatives.

Targanta's climate commitments are aligned with those of Novartis AG, which has established various reduction initiatives. These include targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded to Targanta at a level 2 relationship. This means that Targanta adheres to the sustainability goals and climate strategies defined by Novartis, focusing on significant reductions in greenhouse gas emissions across their operations.

While specific reduction targets for Targanta are not detailed, the overarching commitments from Novartis AG suggest a proactive approach to addressing climate change and reducing carbon footprints. As a current subsidiary, Targanta is expected to contribute to these initiatives, although precise metrics and achievements are not available at this time.